BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3284289)

  • 21. Decreased TcR-CD3+ T cell numbers in healthy aged humans. Evidence that T cell defects are masked by a reciprocal increase of TcR-CD3- CD2+ natural killer cells.
    Alés-Martínez JE; Alvarez-Mon M; Merino F; Bonilla F; Martínez C; Durántez A; De la Hera A
    Eur J Immunol; 1988 Nov; 18(11):1827-30. PubMed ID: 2462502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.
    Maïza H; Leca G; Mansur IG; Schiavon V; Boumsell L; Bensussan A
    J Exp Med; 1993 Sep; 178(3):1121-6. PubMed ID: 7688788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex.
    Anderson P; Caligiuri M; Ritz J; Schlossman SF
    Nature; 1989 Sep; 341(6238):159-62. PubMed ID: 2528695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.
    Bierer BE; Peterson A; Gorga JC; Herrmann SH; Burakoff SJ
    J Exp Med; 1988 Sep; 168(3):1145-56. PubMed ID: 2459290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
    Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
    Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
    Koide J; Rivas A; Engleman EG
    J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only.
    Goedegebuure PS; Segal DM; Braakman E; Vreugdenhil RJ; Van Krimpen BA; Van de Griend RJ; Bolhuis RL
    J Immunol; 1989 Mar; 142(6):1797-802. PubMed ID: 2466076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of T cell receptors in non-MHC-restricted cytotoxicity.
    Lauzon RJ; Siminovitch KA; Roder JC
    Cell Immunol; 1989 Feb; 118(2):265-84. PubMed ID: 2521308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing.
    Uggla CK; Geisberg M; Jondal M; Knowles RW
    Scand J Immunol; 1989 May; 29(5):507-15. PubMed ID: 2567053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the CD45 (T-200) molecule in anti-CD3-triggered T cell-mediated cytotoxicity.
    Deem RL; Shanahan F; Niederlehner A; Targan SR
    Cell Immunol; 1988 Nov; 117(1):99-110. PubMed ID: 2972397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells.
    Uciechowski P; Gessner JE; Schindler R; Schmidt RE
    Eur J Immunol; 1992 Jun; 22(6):1635-8. PubMed ID: 1376268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
    Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells.
    Baume DM; Caligiuri MA; Manley TJ; Daley JF; Ritz J
    Cell Immunol; 1990 Dec; 131(2):352-65. PubMed ID: 2122925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cells in rhesus monkeys: properties of effector cells which lyse Raji targets.
    Carver FM; Thomas JM
    Cell Immunol; 1988 Nov; 117(1):56-69. PubMed ID: 2902933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.
    Lanier LL; Le AM; Cwirla S; Federspiel N; Phillips JH
    Fed Proc; 1986 Nov; 45(12):2823-8. PubMed ID: 3095151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel subset of CD2-, CD3/T cell receptor alpha/beta+ human peripheral blood T cells. Phenotypic and functional characterization of interleukin 2-dependent CD2-CD3+ T cell clones.
    Kabelitz D; Conradt P; Schondelmaier S; Wagner H; Haars R
    J Exp Med; 1989 Aug; 170(2):559-69. PubMed ID: 2569027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
    J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans.
    Poggi A; Pella N; Morelli L; Spada F; Revello V; Sivori S; Augugliaro R; Moretta L; Moretta A
    Eur J Immunol; 1995 Feb; 25(2):369-76. PubMed ID: 7875198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.